Steps to greater accountability in medical education
To remain certified, most of the nation's 700,000 doctors are required periodically to take continuing medical education courses. But critics have said that too many of those courses are little more than drug company marketing in the guise of education. Sponsorship by the pharmaceutical industry pays an estimated half of the cost of such programs in the United States, and critics have argued that the national nonprofit group that accredits the course providers has not done enough to fight drug industry influence in the classroom. But now Murray Kopelow, MD, chief executive of the Accreditation Council for Continuing Medical Education, said he would make public a previously confidential listing of classes and companies that violated rules against commercial bias, the New York Times reports.
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Carondelet to Pay $35M to Settle Fraud Allegations
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- CA Powers Up $80M HIE to 'Create Value in the Data'
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- 3 Traits Personality Assessments Can't Reveal
- Cleveland Clinic Partners with North Shore-LIJ for Heart Care